Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEGASYS with or without COPEGUS in chronic hepatitis C patients from previous Roche protocols
2004-001718-15Phase 3Terminated
- Sponsor
- Roche
- Start
- Feb 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of peginterferon alfa-2a in hepatitis C virus infection (2 arms), sponsored by Roche. Started Feb 2007; status: terminated.
02
Drugs
peginterferon alfa-2a
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2004-001718-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001718-15.